The NCT01206582 trial is a pilot study designed to learn if hemin can increase the production of HO-1 and improve gastric (stomach) emptying and symptoms in diabetic patients with slow gastric emptying (gastroparesis). The gene discussed is HMOX1; the disease is gastroparesis.